Signal transduction through interferon-gamma receptor on human eosinophils

BACKGROUND: We reported on the constitutive interferon-gamma receptor (IFN-gammaR) expression on eosinophils. But signal transduction through IFN-gammaR on eosinophils remains to be elucidated. In this study, we examined the involvement of the Jak/Stat pathway in the signaling of eosinophils after IFN-gammaR conjugation by the ligand binding. METHODS: Purified peripheral eosinophils were stimulated with IFN-gamma at 37 degrees C for 1-60 min. Tyrosine phosphorylation of IFN-gammaR, Jak1, Jak2, and Stat1alpha was examined by immunoblotting. Gel-shift assay was also examined to show the formation of Stat1alpha-DNA complexes. RESULTS: We show that binding of IFN-gamma to human eosinophils initiated a series of events that resulted in the rapid tyrosine phosphorylation of not only the IFN-gammaRalpha chain but also Jak1, Jak2, and Stat1alpha. In addition, IFN-gamma enhanced the DNA-binding activity of Stat1alpha. CONCLUSION: These data indicate that IFN-gamma affects eosinophils through its specific receptor and utilizes the Jak/Stat pathway as its mode of signaling.     

Signal transduction by the T cell antigen receptor.

The T cell antigen receptor (TCR) must recognize antigen, and translate this recognition event into intracellular signal transduction events. Two signal transduction events are regulated by the TCR: the activation of a protein tyrosine kinase (PTK) and phospholipase C (PLC). Recent studies suggest that the TCR-activated PTK regulates PLC activation by the phosphorylation of tyrosine residues of PLC gamma 1. The complex structure of the TCR is now being related to its signal transduction function. Studies with chimeric receptors reveal that the antigen binding Ti heterodimer communicates with the subunits involved with signal transduction, the CD3 chains and zeta dimers, through the carboxy-terminal regions of the Ti chains that surround and include the transmembrane domains. Other chimeras have helped demonstrate that the zeta chain family of dimers function to couple the TCR to intracellular signal transduction mechanisms. The signal transduction function of the TCR can be regulated in a number of ways and by other T cell surface molecules. The plasma membrane tyrosine phosphatase CD45, plays a critical role to specifically regulate TCR-mediated activation of PTK's and PLC. Thus, an understanding of the complex structure of the TCR and the intricacies of its signal transduction function is rapidly emerging.     

衰老的信号转导

长生不老是每个人的最大心愿，这在以前只能是一个梦想，然而，在科学技术尤其是分子生物学技术高度发达的今天，这一梦想将可能变为现实，事实上研究人员通过分子生物学方法抑制衰老信号转导途径的衰老基因表达已经在细胞水平能够延缓细胞的衰老，从这里我们可以看出衰老信号转导研究对抗衰老研究至关重要，事实上衰老的信号转导研究已经成为衰老研究和抗衰老研究最有吸引力的领域之一，本文就这一领域的最新进展作一综述。     

Signal transduction through the human IL-2 receptor beta-chain expressed in IL-6-dependent mouse B cell hybridoma

Non-covalent association between at least two polypeptides, alpha (p55) and beta (p70), yields a high-affinity interleukin 2 receptor (IL-2R). Recent findings suggest that the beta-chain can mediate IL-2 signals on its own, while the alpha-chain is not involved in IL-2 signal transduction. To study the role of the beta-chain, directly, we transfected with the human IL-2R beta-chain cDNA a murine IL-6-dependent B cell hybridoma, F12-28, which originally did not express IL-2R. We established a stable transformant, beta E12, expressing the beta-chain (Kd = 1300 pM, 3000 sites/cell) in the absence of any detectable alpha-chain. We showed that (i) beta E12 manifested the intermediate affinity IL-2 binding, which was completely blocked with anti-human beta-chain antibody (Mik-beta 1); (ii) beta E12 acquired an ability to proliferate in response to IL-2 (greater than 0.1 nM) in a dose-dependent manner. These results clearly demonstrate that the beta-chain itself is directly involved in IL-2 signal transduction in the absence of the alpha-chain. Our results also suggest that a certain IL-6-dependent B cell line possesses cellular components) capable of transducing IL-2 signals.     

Signal transduction by human NK cell MHC-recognizing receptors

Summary: Cells may be protected from natural killer (NK)-cell-mediated killing by the expression of specific MHC class I complexes. This protective effect is due to the expression on NK cells of MHC class I-recognizing receptors which, upon ligation, transduce potent inhibitory signals into the NK cells. The molecular signalling mechanisms employed by the human NK-cell MHC-recognizing killer cell inhibitory receptors (KIR) and CD94 are the focus of this review, A sequential model of KIR signalling involving lck-dependent tyrosine phosphorylation of KIR and subsequent association of KIR with the SH2 -containing tyrosine phosphatase, SHP-1, is presented. We explore how engagement of either KIR m CD94 modulates the protein tyrosine kinase-dependent biochemical signals responsible for activation of NK-ceil cytotoxic function. Additionally, we discuss models of inhibitory signalling proposed for each of the lymphocyte lineages, emphasizing that disparate molecular mechanisms may be utilized by ceils to produce similar biological responses.     

Optimising stable retroviral transduction of primary human synovial fibroblasts

Fibroblast like synoviocytes are the main resident cells in normal joints and are known to play a major role in the pathogenesis of rheumatoid arthritis. Efficient gene targeting of fibroblast like synoviocytes (FLS) is a major goal of current ex vivo gene therapy approaches for the treatment of rheumatoid arthritis. However, there is a need to improve viral systems capable of delivering genes to human rheumatoid fibroblasts and attempts have been made to develop a protocol for high efficiency, reproducible gene transfer using a replication-defective retrovirus vector. The effects of different experimental conditions were examined as well as those related to cellular and viral features on the efficiency of transducing the retroviral-driven expression of enhanced green fluorescent protein (EGFP) to FLS harvested from patients with rheumatoid arthritis. The optimal method established involved a double round of infection by centrifugation with a resting period of 4h between rounds. This approach led to the transduction of 30-70% of FLS obtained from nine patients with rheumatoid arthritis. Consistent transduction efficiencies were achieved in repeat assays such that it could be inferred that the variations observed were attributable to the specific characteristics of each cell line. This simple protocol renders a consistent and reproducible efficiency of rheumatoid fibroblast transduction and makes stable gene targeting using non-replicating retrovirus derived vectors an affordable option for the treatment of rheumatoid arthritis.     

EGF and dextran-conjugated EGF induces differential phosphorylation of the EGF receptor

Dextran-conjugated EGF (EGF-dextran) has a potential use for targeted radionuclide therapy of tumors that overexpress the epidermal growth factor receptor (EGFR). There are plans to treat both bladder carcinomas and malignant gliomas with local injections of radiolabeled EGF-dextran since these tumors often express high levels of EGFR. In this report we show that EGF and EGF-dextran differentially activate the EGFR. In the human glioma cell line U-343, activation of the serine/threonine kinases Erk and Akt is identical upon stimulation with EGF or EGF-dextran. However, the effect on phospholipase Cgamma1 (PLCgamma1) phosphorylation differs. In cells stimulated with EGF-dextran, the PLCgamma1 phosphorylation is lower than in cells stimulated with EGF. This observation could be explained by the fact that the PLCgamma1 association sites in the EGFR, tyrosine residues 992 and 1173, were phosphorylated to a lower degree when the receptor was stimulated with EGF-dextran as compared to with EGF.     

Signal transduction elements of the B cell antigen receptor and their role in immunodeficiencies

The primary function of B lymphocytes is to contribute to the elimination of foreign antigens by producing large amounts of soluble antibodies. The activation of B cells through their antigen receptor triggers a dynamic network of intracellular signaling proteins. The recent identification of the cytoplasmic adaptor protein SLP-65 (also called BLNK or BASH) provided insight in how the antigen receptor-regulated protein tyrosine kinases couple to downstream signaling cascades, including the mobilization of Ca2+ ions, activation of mitogen-activated kinases and reorganization of the cytoskeleton architecture. While these events have been mostly studied in mature B cells, it is now clear that the components of the antigen receptor and its downstream effector elements play also a central role during early and late B cell development, and in the apoptotic elimination of B cells with reactivity to self-antigens. Thus, genetic defects affecting the expression of antigen receptor subunits or its intracellular signaling proteins can interfere with B cell development and activation, and can cause severe antibody deficiencies in mouse and man. In this article I summarize our current picture of the B cell antigen receptor, how the extracellular signal is transported into the cell interior, and how dysregulation of these processes contribute to immune defects.     

Signal transduction targets in invasion

The processes of physiologic and malignant invasion use the same cellular pathways, albeit under differential regulation. Critical signaling messages can be initiated through cell-cell and cell-substratum contact, as well as using autocrine and paracrine activation. Cancer cells are known for their flexibility and autocrine functions, however, they still rely on a battery of important signaling events. The interaction between the tumor cell and the stroma provides an important signaling milieu and target zone for molecular therapeutic intervention. It is now recognized that malignant invasion requires that interaction for optimal signaling and function. New technologies are now available to allow more rapid dissection of these pathways and characterization of unique regulatory sites for therapeutic gain. This revised version was published online in July 2006 with corrections to the Cover Date.     

Signal transduction in B lymphocytes

We have examined the activity and intracellular compartmentalization of protein kinase C (PKC) following activation of human B lymphocytes by anti-human leukocyte antigen (HLA) class II antibodies. 12-O-Tetradecanoylphorbol 13-acetate (TPA) treatment increased membrane-associated PKC (between five and nine times greater than the control value) and decreased cytosolic PKC (between 70% and 100% of the control value). In contrast, anti-class II antibodies induce an activation of PKC which results either in an increase of cytosolic activity or membrane-bound activity without redistribution of cytosolic PKC. The effect of TPA and HLA class II molecules on total PKC activity was comparable: when TPA induced an increase of total PKC activity so did HLA class II molecules and when TPA did not, HLA class II molecules did not. Measurement on SDS PAGE of histone phosphorylation confirmed the above results of PKC activity. Taken together, our results suggest that PKC might be implicated in HLA class II-induced B lymphocyte activation.